Log in

NASDAQ:SIENSientra Stock Price, Forecast & News

$4.19
+0.24 (+6.08 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.90
Now: $4.19
$4.20
50-Day Range
$3.64
MA: $3.97
$4.45
52-Week Range
$1.00
Now: $4.19
$9.71
Volume972,798 shs
Average Volume1.01 million shs
Market Capitalization$209.63 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Read More
Sientra logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIEN
CUSIPN/A
Phone805-562-3500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$83.70 million
Book Value$1.65 per share

Profitability

Net Income$-106,820,000.00
Net Margins-134.87%

Miscellaneous

Employees339
Market Cap$209.63 million
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$4.19
+0.24 (+6.08 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sientra (NASDAQ:SIEN) Frequently Asked Questions

How has Sientra's stock been impacted by COVID-19 (Coronavirus)?

Sientra's stock was trading at $2.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SIEN shares have increased by 71.7% and is now trading at $4.19.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Sientra?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sientra
.

When is Sientra's next earnings date?

Sientra is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Sientra
.

How can I listen to Sientra's earnings call?

Sientra will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Sientra's earnings last quarter?

Sientra Inc (NASDAQ:SIEN) issued its quarterly earnings results on Monday, May, 11th. The medical instruments supplier reported ($0.57) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.49) by $0.08. The medical instruments supplier earned $16.93 million during the quarter, compared to the consensus estimate of $18.70 million. Sientra had a negative net margin of 134.87% and a negative return on equity of 101.94%.
View Sientra's earnings history
.

What price target have analysts set for SIEN?

6 equities research analysts have issued 1 year price targets for Sientra's shares. Their forecasts range from $5.00 to $9.00. On average, they expect Sientra's share price to reach $6.46 in the next twelve months. This suggests a possible upside of 54.2% from the stock's current price.
View analysts' price targets for Sientra
.

Has Sientra been receiving favorable news coverage?

Press coverage about SIEN stock has trended very positive on Saturday, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sientra earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Sientra
.

Are investors shorting Sientra?

Sientra saw a decrease in short interest in July. As of July 31st, there was short interest totaling 3,750,000 shares, a decrease of 24.2% from the July 15th total of 4,950,000 shares. Based on an average trading volume of 1,770,000 shares, the short-interest ratio is currently 2.1 days. Currently, 8.7% of the shares of the company are sold short.
View Sientra's Short Interest
.

Who are some of Sientra's key competitors?

What other stocks do shareholders of Sientra own?

Who are Sientra's key executives?

Sientra's management team includes the following people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 73, Pay $1.92M)
  • Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 55, Pay $513.65k)
  • Mr. Charles Huiner, Consultant (Age 49, Pay $558.46k)
  • Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 62, Pay $40k)
  • Ms. Deborah Bettencourt, VP of HR & Corp. Admin.

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Who are Sientra's major shareholders?

Sientra's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (4.82%), Mutual of America Capital Management LLC (2.62%), Assenagon Asset Management S.A. (1.00%), SG Americas Securities LLC (0.05%), Wedbush Securities Inc. (0.02%) and Principal Financial Group Inc. (0.02%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Paul Sean Little and Timothy Haines.
View institutional ownership trends for Sientra
.

Which institutional investors are selling Sientra stock?

SIEN stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, and SG Americas Securities LLC.
View insider buying and selling activity for Sientra
.

Which institutional investors are buying Sientra stock?

SIEN stock was purchased by a variety of institutional investors in the last quarter, including Mutual of America Capital Management LLC, Assenagon Asset Management S.A., Wedbush Securities Inc., and Principal Financial Group Inc.. Company insiders that have bought Sientra stock in the last two years include Keith J Sullivan, and Paul Sean Little.
View insider buying and selling activity for Sientra
.

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $4.19.

How big of a company is Sientra?

Sientra has a market capitalization of $209.63 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 339 workers across the globe.

What is Sientra's official website?

The official website for Sientra is www.sientra.com.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.